Charpin C - Search Results

1

[Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].

Dales JP, Garcia S, Bonnier P, Duffaud F, Carpentier S, Djemli A, Ramuz O, Andrac L, Lavaut M, Allasia C, Charpin C. Dales JP, et al. Among authors: charpin c. Ann Pathol. 2003 Sep;23(4):297-305. Ann Pathol. 2003. PMID: 14597894 French.

2

Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression.

Dales JP, Garcia S, Carpentier S, Andrac L, Ramuz O, Lavaut MN, Allasia C, Bonnier P, Charpin C. Dales JP, et al. Among authors: charpin c. Hum Pathol. 2004 Feb;35(2):176-83. doi: 10.1016/j.humpath.2003.10.008. Hum Pathol. 2004. PMID: 14991534

3

Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.

Dales JP, Garcia S, Andrac L, Carpentier S, Ramuz O, Lavaut MN, Allasia C, Bonnier P, Charpin C. Dales JP, et al. Among authors: charpin c. Int J Oncol. 2004 May;24(5):1197-204. Int J Oncol. 2004. PMID: 15067342

4

Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma.

Meunier-Carpentier S, Dales JP, Djemli A, Garcia S, Bonnier P, Andrac-Meyer L, Lavaut MN, Allasia C, Charpin C. Meunier-Carpentier S, et al. Among authors: charpin c. Int J Oncol. 2005 Apr;26(4):977-84. Int J Oncol. 2005. PMID: 15753992

5

Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breast carcinomas.

Charpin C, Giusiano S, Secq V, Carpentier S, Andrac L, Lavaut MN, Allasia C, Bonnier P, Garcia S. Charpin C, et al. Int J Oncol. 2009 Apr;34(4):983-93. doi: 10.3892/ijo_00000224. Int J Oncol. 2009. PMID: 19287955

6

[Immunohistochemical detection of estrogen receptors and image analysis (SAMBA 200) in breast carcinomas].

Charpin C, Martin PM, Andrac L, Lavaut MN, Vacheret H, Habib MC, Toga M. Charpin C, et al. Ann Pathol. 1988;8(3):196-210. Ann Pathol. 1988. PMID: 3178938 French.

7

[Prognostic value of E-cadherin expression in hepatocellular carcinoma].

Garcia S, Martini F, De Micco C, Andrac L, Sappa P, Hardwigsen J, Lavaut MN, Le Treut YP, Charpin C. Garcia S, et al. Among authors: charpin c. Ann Pathol. 1998 Apr;18(2):98-102. Ann Pathol. 1998. PMID: 9608861 French.

8

[An unusual subcutaneous tumor].

Dorel-Le Theo M, Andrac-Meyer L, Dales JP, Crebassa B, Koeppel MC, Charpin C. Dorel-Le Theo M, et al. Among authors: charpin c. Ann Pathol. 2002 Jun;22(3):235-6. Ann Pathol. 2002. PMID: 12410111 French. No abstract available.

9

Tie2/Tek expression in breast carcinoma: correlations of immunohistochemical assays and long-term follow-up in a series of 909 patients.

Dales JP, Garcia S, Bonnier P, Duffaud F, Meunier-Carpentier S, Andrac-Meyer L, Lavaut MN, Allasia C, Charpin C. Dales JP, et al. Among authors: charpin c. Int J Oncol. 2003 Feb;22(2):391-7. Int J Oncol. 2003. PMID: 12527939

10

Tumor neoangiogenesis by CD31 and CD105 expression evaluation in breast carcinoma tissue microarrays.

Charpin C, Dales JP, Garcia S, Carpentier S, Djemli A, Andrac L, Lavaut MN, Allasia C, Bonnier P. Charpin C, et al. Clin Cancer Res. 2004 Sep 1;10(17):5815-9. doi: 10.1158/1078-0432.CCR-04-0021. Clin Cancer Res. 2004. PMID: 15355911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters